Provided by Tiger Fintech (Singapore) Pte. Ltd.

Boston Scientific

95.12
-0.1300-0.14%
Post-market: 96.100.9850+1.04%19:59 EDT
Volume:6.67M
Turnover:636.84M
Market Cap:140.69B
PE:76.10
High:96.06
Open:95.60
Low:94.67
Close:95.25
Loading ...

Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term

Zacks
·
03 Mar

Rpt-Boston Scientific Corp - Transaction Includes $360 Mln Upfront, $180 Mln Regulatory Milestone

THOMSON REUTERS
·
03 Mar

Rpt-Boston Scientific Announces Agreement to Acquire Sonivie Ltd.

THOMSON REUTERS
·
03 Mar

Corrected-Boston Scientific Corp - Transaction Expected to Be Slightly Dilutive to Adjusted EPS in 2025 (Adds Dropped Word 'Adjusted')

THOMSON REUTERS
·
03 Mar

1 Growth Stock with All-Star Potential and 2 to Brush Off

StockStory
·
03 Mar

Boston Scientific to Acquire Medical Device Firm SoniVie

MT Newswires Live
·
03 Mar

Boston Scientific to Buy Rest of SoniVie for Initial $360 Million

Dow Jones
·
03 Mar

BRIEF-Boston Scientific Announces Agreement To Acquire Sonivie

Reuters
·
03 Mar

Boston Scientific Corp - Transaction Expected to Be Slightly Dilutive to EPS in 2025

THOMSON REUTERS
·
03 Mar

Boston Scientific Announces Agreement to Acquire Sonivie Ltd.

THOMSON REUTERS
·
03 Mar

Boston Scientific Corp - Transaction Includes $360 Mln Upfront, $180 Mln Regulatory Milestone

THOMSON REUTERS
·
03 Mar

Boston Scientific announces agreement to acquire SoniVie Ltd.

PR Newswire
·
03 Mar

The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard

Zacks
·
03 Mar

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Mar

Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific

Zacks
·
01 Mar

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

Zacks
·
01 Mar

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands

Zacks
·
01 Mar

Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail

Zacks
·
01 Mar

Alcon Stock Gains From Innovation Despite Macroeconomic Troubles

Zacks
·
01 Mar

Is it Apt to Retain Omnicell Stock in Your Portfolio Now?

Zacks
·
28 Feb